Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.81 USD | -6.91% | -19.40% | +27.20% |
May. 15 | Solid Biosciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 01 | Solid Biosciences' SGT-003 Receives US FDA's Rare Pediatric Disease Label | MT |
Financials (USD)
Sales 2024 * | 3.73M | Sales 2025 * | 4.44M | Capitalization | 318M |
---|---|---|---|---|---|
Net income 2024 * | -101M | Net income 2025 * | -123M | EV / Sales 2024 * | 45 x |
Net cash position 2024 * | 150M | Net cash position 2025 * | 67.4M | EV / Sales 2025 * | 56.4 x |
P/E ratio 2024 * |
-3.07
x | P/E ratio 2025 * |
-3.1
x | Employees | 88 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.17% |
Latest transcript on Solid Biosciences Inc.
1 day | -6.91% | ||
1 week | -19.40% | ||
Current month | -11.95% | ||
1 month | -13.61% | ||
3 months | -17.88% | ||
6 months | +198.09% | ||
Current year | +27.20% |
Managers | Title | Age | Since |
---|---|---|---|
Annie Ganot
FOU | Founder | - | 13-02-28 |
Ilan Ganot
FOU | Founder | 50 | 13-02-28 |
Alexander Cumbo
CEO | Chief Executive Officer | 53 | 22-09-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ian Smith
CHM | Chairman | 58 | 20-04-14 |
Martin Freed
BRD | Director/Board Member | 63 | 18-06-25 |
Raj Shah
BRD | Director/Board Member | 46 | 17-02-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 7.81 | -6.91% | 162,317 |
24-05-22 | 8.39 | -1.41% | 128,736 |
24-05-21 | 8.51 | -6.69% | 437,680 |
24-05-20 | 9.12 | +1.90% | 210,376 |
24-05-17 | 8.95 | -3.76% | 211,280 |
Delayed Quote Nasdaq, May 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.20% | 318M | |
+10.79% | 115B | |
+11.65% | 106B | |
-6.20% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.41% | 17.56B | |
-40.50% | 17.32B | |
+6.64% | 14.03B | |
+31.84% | 12.13B |
- Stock Market
- Equities
- SLDB Stock